Satellos Bioscience Cash Flow Statement (2025-2026) | MSLE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2025 Mar2026
Operating Activities
Net Income (Quarter) 6.14M-9.77M
Depreciation and Depletion (Quarter) 0.00M0.00M
Share-based Compensation (Quarter) 0.64M0.73M
Non-cash Items (Quarter) 7.37M51.90M
Change in Working Capital (Quarter) 7.37M-9.59M
Change in Accured Expenses (Quarter) -0.89M0.42M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.00M0.00M
Investing Activities
Capital Expenditures (Quarter) -0.00M
Divestments (Quarter) -33.34M
Change in Acquisitions & Divestments (Quarter) 10.55M
Financing Activities
Other financing activities (Quarter) 0.00M51.90M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 47.25M
Misc.
Exchange Rate Effect (Quarter) 0.00M-0.09M
Change in Cash (Quarter) -7.36M8.89M
Beginning Cash Balance (Quarter) 40.07M9.80M
Free Cash Flow (Quarter) 0.00M